AFFY (Affymax) Total Liabilities: $0.21 Mil (As of Jun. 2014)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Affymax Total Liabilities?

Affymax AFFY +6.67% Total Liabilities is $0.21 Mil as of Jun. 2014.

Affymax's Total Liabilities for the quarter that ended in Jun. 2014 was $0.21 Mil.

Affymax's quarterly Total Liabilities declined from Dec. 2013 ($8.87 Mil) to Mar. 2014 ($8.80 Mil) and declined from Mar. 2014 ($8.80 Mil) to Jun. 2014 ($0.21 Mil).

Affymax's annual Total Liabilities increased from Dec. 2011 ($43.00 Mil) to Dec. 2012 ($109.94 Mil) but then declined from Dec. 2012 ($109.94 Mil) to Dec. 2013 ($8.87 Mil).

Affymax Total Liabilities Historical Data

* Premium members only.

The historical data trend for Affymax's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Affymax Total Liabilities Chart

Affymax Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 144.61 58.84 43.00 109.94 8.87

Affymax Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.59 16.41 8.87 8.80 0.21

Affymax Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Affymax's Total Liabilities for the fiscal year that ended in Dec. 2013 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.871+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=8.87

Total Liabilities=Total Assets (A: Dec. 2013 )-Total Equity (A: Dec. 2013 )
=7.443--1.428
=8.87

Affymax's Total Liabilities for the quarter that ended in Jun. 2014 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.214+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.21

Total Liabilities=Total Assets (Q: Jun. 2014 )-Total Equity (Q: Jun. 2014 )
=5.384-5.17
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.21 Mil mean?
Affymax (AFFY) has a Total Liabilities of $0.21 Mil as of Jun. 2014. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Affymax and its competitors.
Is Affymax's Total Liabilities too high?
Affymax's current Total Liabilities is $0.21 Mil.
How does Affymax's Total Liabilities compare to APOP and ONTX?
Affymax's Total Liabilities of $0.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Affymax and its competitors. Affymax's current Total Liabilities is $0.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Affymax stock overvalued right now?
Affymax (AFFY) has a current Total Liabilities of $0.21 Mil. The current Total Liabilities is $0.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Affymax (AFFY), the current Total Liabilities is $0.21 Mil as of Jun. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Affymax Business Description

Address 630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.